Bellevue Group AG - Q1 2017 holdings

$750 Million is the total value of Bellevue Group AG's 132 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 16.4% .

 Value Shares↓ Weighting
CELG BuyCELGENE CORP$31,279,000
+35.4%
251,380
+25.9%
4.17%
-11.9%
AMGN BuyAMGEN INC$25,505,000
+108.9%
155,450
+86.2%
3.40%
+36.0%
INCY BuyINCYTE CORP$24,990,000
+65.7%
186,950
+24.3%
3.33%
+7.8%
CNC BuyCENTENE CORP DEL$20,903,000
+143.9%
293,340
+93.5%
2.79%
+58.7%
UNH BuyUNITEDHEALTH GROUP INC$20,327,000
+15.5%
123,940
+12.7%
2.71%
-24.9%
GILD BuyGILEAD SCIENCES INC$19,726,000
+53.5%
290,428
+61.8%
2.63%
-0.1%
MDT SellMEDTRONIC PLC$19,536,000
+5.7%
242,500
-6.6%
2.60%
-31.2%
ANTM BuyANTHEM INC$18,268,000
+516.7%
110,460
+436.2%
2.43%
+301.0%
ABT  ABBOTT LABS$18,008,000
+15.6%
405,5000.0%2.40%
-24.8%
ILMN BuyILLUMINA INC$16,884,000
+145.1%
98,944
+83.9%
2.25%
+59.5%
ISRG BuyINTUITIVE SURGICAL INC$16,805,000
+194.4%
21,925
+143.6%
2.24%
+91.5%
SYK SellSTRYKER CORP$16,136,000
-13.3%
122,570
-21.1%
2.15%
-43.6%
ALGN NewALIGN TECHNOLOGY INC$15,624,000136,200
+100.0%
2.08%
JAZZ BuyJAZZ PHARMACEUTICALS PLC$15,471,000
+69.3%
106,600
+27.2%
2.06%
+10.2%
BIIB BuyBIOGEN INC$14,628,000
+5.3%
53,500
+9.2%
1.95%
-31.5%
HOLX BuyHOLOGIC INC$14,573,000
+65.4%
342,490
+56.0%
1.94%
+7.6%
BSX BuyBOSTON SCIENTIFIC CORP$14,226,000
+19.6%
572,000
+4.0%
1.90%
-22.2%
WBA NewWALGREENS BOOTS ALLIANCE INC$13,322,000160,409
+100.0%
1.78%
LGND SellLIGAND PHARAMCEUTICALS INC$12,546,000
-0.8%
118,540
-4.8%
1.67%
-35.5%
BCR SellBARD C R INC$12,037,000
+4.9%
48,430
-5.2%
1.60%
-31.8%
AKRXQ BuyAKORN INC$11,910,000
+18.6%
494,600
+7.5%
1.59%
-22.8%
EW  EDWARDS LIFESCIENCES CORP$11,759,000
+0.4%
125,0000.0%1.57%
-34.7%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDadr$11,751,000
+38.0%
366,172
+55.8%
1.57%
-10.2%
SHPG BuySHIRE PLCsponsored adr$11,447,000
+179.9%
65,700
+173.8%
1.52%
+82.2%
REGN SellREGENERON PHARMACEUTICALS$11,354,000
-4.2%
29,300
-9.3%
1.51%
-37.7%
LLY BuyELI LILLY & CO$11,052,000
+329.4%
131,400
+275.4%
1.47%
+179.5%
ZBH SellZIMMER BIOMET HLDGS INC$10,746,000
+1.1%
88,000
-14.6%
1.43%
-34.2%
MYL BuyMYLAN N V$10,028,000
+11.5%
257,200
+9.1%
1.34%
-27.4%
BAX  BAXTER INTL INC$9,853,000
+16.9%
190,0000.0%1.31%
-23.9%
DHR BuyDANAHER CORP DEL$9,750,000
+69.3%
114,000
+54.1%
1.30%
+10.1%
ABC NewAMERISOURCEBERGEN CORP$9,036,000102,099
+100.0%
1.20%
WMGI BuyWRIGHT MED GROUP NV$8,983,000
+3805.7%
288,663
+2786.6%
1.20%
+2446.8%
ALXN BuyALEXION PHARMACEUTICALS INC$8,608,000
+42.4%
71,000
+43.7%
1.15%
-7.4%
VRTX SellVERTEX PHARMACEUTICALS INC$8,310,000
+39.3%
76,000
-6.2%
1.11%
-9.4%
IONS BuyIONIS PHARMACEUTICALS INC$8,251,000
+89.5%
205,253
+125.6%
1.10%
+23.5%
MNKKQ BuyMALLINCKRODT PUB LTD CO$8,144,000
+102.3%
182,725
+126.1%
1.08%
+31.7%
ABMD BuyABIOMED INC$7,972,000
+57.1%
63,670
+41.3%
1.06%
+2.2%
HZNP BuyHORIZON PHARMA PLC$7,372,000
+1800.0%
498,765
+1978.2%
0.98%
+1143.0%
ALNY BuyALNYLAM PHARMACEUTICALS INC$7,272,000
+708.9%
141,900
+491.2%
0.97%
+426.6%
HRC NewHILL-ROM HOLDINGS INC$7,221,000102,274
+100.0%
0.96%
AGN SellALLERGAN PLC$6,929,000
+12.2%
29,000
-1.4%
0.92%
-27.0%
ABBV BuyABBVIE INC$6,692,000
+612.7%
102,701
+584.7%
0.89%
+364.6%
PRGO BuyPERRIGO CO PLC$6,268,000
+159.7%
94,411
+225.6%
0.84%
+69.0%
ALR BuyALERE INC$5,775,000
+208.8%
145,363
+202.9%
0.77%
+101.0%
THC NewTENET HEALTHCARE CORP$5,766,000325,546
+100.0%
0.77%
BMRN  BIOMARIN PHARMACEUTICAL INC$5,706,000
+6.0%
65,0000.0%0.76%
-31.1%
MGNX BuyMACROGENICS INC$5,666,000
+233.9%
304,597
+267.0%
0.76%
+117.0%
EGRX BuyEAGLE PHARMACEUTICALS INC$5,615,000
+73.9%
67,700
+66.3%
0.75%
+13.2%
BDX SellBECTON DICKINSON & CO$5,503,000
-16.9%
30,000
-25.0%
0.73%
-45.9%
AET BuyAETNA INC NEW$5,434,000
+167.2%
42,600
+159.8%
0.72%
+73.6%
CI SellCIGNA CORPORATION$4,834,000
-3.9%
33,000
-12.5%
0.64%
-37.5%
CERN SellCERNER CORP$4,384,000
-6.0%
74,500
-24.4%
0.58%
-38.9%
NKTR SellNEKTAR THERAPEUTICS$4,036,000
+76.9%
172,000
-7.5%
0.54%
+15.2%
GNMK NewGENMARK DIAGNOSTICS INC.$4,008,000312,666
+100.0%
0.53%
COO  COOPER COS INC$3,998,000
+14.3%
20,0000.0%0.53%
-25.7%
JNJ SellJOHNSON & JOHNSON$3,923,000
-10.4%
31,500
-17.1%
0.52%
-41.7%
HUM BuyHUMANA INC$3,917,000
+23.9%
19,000
+22.6%
0.52%
-19.4%
CHRS  COHERUS BIOSCIENCES INC$3,701,000
-24.9%
175,0000.0%0.49%
-51.1%
MCK  MCKESSON CORP$3,558,000
+5.5%
24,0000.0%0.47%
-31.3%
IBB BuyISHARES TRnasdq biotec etf$3,519,000
+231.4%
12,000
+200.0%
0.47%
+116.1%
HALO SellHALOZYME THERAPEUTICS INC$3,499,000
+11.4%
270,000
-15.1%
0.47%
-27.5%
ESRX  EXPRESS SCRIPTS HLDG CO$3,263,000
-4.2%
49,5000.0%0.44%
-37.6%
LIVN NewLIVANOVA PLC$3,146,00064,189
+100.0%
0.42%
DXCM SellDEXCOM INC$3,059,000
+25.0%
36,100
-12.0%
0.41%
-18.6%
NBIX SellNEUROCRINE BIOSCIENCES INC$2,944,000
+1.4%
68,000
-9.3%
0.39%
-34.0%
RARE SellULTRAGENYX PHARMACEUTICAL INC$2,847,000
-5.8%
42,000
-2.3%
0.38%
-38.8%
XRAY NewDENTSPLY SIRONA INC$2,810,00045,000
+100.0%
0.37%
BLUE  BLUEBIRD BIO INC$2,636,000
+47.3%
29,0000.0%0.35%
-4.1%
AGIO  AGIOS PHARMACEUTICALS INC$2,628,000
+39.9%
45,0000.0%0.35%
-9.1%
CVS BuyCVS HEALTH CORP$2,622,000
+242.7%
33,400
+244.3%
0.35%
+122.3%
TSRO NewTESARO INC$2,462,00016,000
+100.0%
0.33%
SGEN SellSEATTLE GENETICS INC$2,452,000
+8.1%
39,000
-9.3%
0.33%
-29.7%
NUVA SellNUVASIVE INC$2,338,000
-0.8%
31,304
-10.6%
0.31%
-35.4%
ALKS SellALKERMES PLC$2,311,000
-2.2%
39,500
-7.1%
0.31%
-36.4%
QGEN SellQIAGEN NV$2,302,000
-10.2%
79,444
-13.2%
0.31%
-41.5%
PRTA  PROTHENA CORP PLC$2,287,000
+13.4%
41,0000.0%0.30%
-26.2%
MASI SellMASIMO$2,145,000
+6.1%
23,000
-23.3%
0.29%
-30.9%
EARS  AURIS MED HLDG AG$1,996,000
-14.0%
2,169,6250.0%0.27%
-44.0%
TMO SellTHERMO FISHER SCIENTIFIC INC$1,997,000
-11.6%
13,000
-18.8%
0.27%
-42.4%
HCA SellHCA HOLDINGS INC$1,896,000
+7.6%
21,300
-10.5%
0.25%
-29.9%
LH BuyLABORATORY CORP AMER HLDGS$1,865,000
+81.6%
13,000
+62.5%
0.25%
+18.6%
ANGO  ANGIODYNAMICS INC$1,765,000
+2.9%
101,7000.0%0.24%
-33.0%
MRK  MERCK & CO INC$1,747,000
+7.9%
27,5000.0%0.23%
-29.8%
XENT SellINTERSECT ENT INC$1,715,000
+9.0%
100,000
-23.1%
0.23%
-28.9%
PFE  PFIZER INC$1,711,000
+5.4%
50,0000.0%0.23%
-31.5%
CAH  CARDINAL HEALTH INC$1,631,000
+13.3%
20,0000.0%0.22%
-26.4%
ACAD  ACADIA PHARMACEUTICALS INC$1,547,000
+19.2%
45,0000.0%0.21%
-22.6%
RDUS SellRADIUS HEALTH INC$1,411,000
-7.2%
36,500
-8.8%
0.19%
-39.5%
PTLA  PORTOLA PHARMACEUTICALS INC$1,411,000
+74.6%
36,0000.0%0.19%
+13.9%
ENDP SellENDO INTL PLC$1,283,000
-37.2%
115,000
-7.3%
0.17%
-59.1%
TFX  TELEFLEX INC$1,259,000
+20.2%
6,5000.0%0.17%
-21.5%
BMY  BRISTOL MYERS SQUIBB CO$1,251,000
-6.9%
23,0000.0%0.17%
-39.3%
BIVV NewBIOVERATIV INC$1,239,00022,750
+100.0%
0.16%
ZLTQ SellZELTIQ AESTHETICS INC$1,223,000
-53.2%
22,000
-63.3%
0.16%
-69.5%
GMED SellGLOBUS MED INCcl a$1,185,000
-45.5%
40,000
-54.4%
0.16%
-64.6%
CLVS SellCLOVIS ONCOLOGY INC$1,178,000
+32.7%
18,500
-7.5%
0.16%
-13.7%
NVDQ SellNOVADAQ TECHNOLOGIES INC$1,169,000
-28.3%
150,000
-34.8%
0.16%
-53.3%
ESPR SellESPERION THERAPEUTICS INC NEW$1,130,000
+125.5%
32,000
-20.0%
0.15%
+46.6%
EXEL SellEXELIXIS INC$1,127,000
+25.9%
52,000
-13.3%
0.15%
-18.0%
KITE  KITE PHARMA INC$1,099,000
+75.0%
14,0000.0%0.15%
+13.2%
UTHR  UNITED THERAPEUTICS CORP DEL$1,056,000
-5.6%
7,8000.0%0.14%
-38.4%
MDCO NewMEDICINES CO$1,051,00021,500
+100.0%
0.14%
GKOS  GLAUKOS CORP$1,026,000
+49.6%
20,0000.0%0.14%
-2.1%
ICPT  INTERCEPT PHARMACEUTICALS IN$961,000
+4.0%
8,5000.0%0.13%
-32.3%
INO SellINOVIO PHARMACEUTICALS INC$953,000
-11.4%
144,000
-7.1%
0.13%
-42.3%
NVRO  NEVRO CORP$815,000
+29.0%
8,7000.0%0.11%
-15.5%
JUNO  JUNO THERAPEUTICS INC$821,000
+17.8%
37,0000.0%0.11%
-23.8%
EVHC  ENVISION HEALTHCARE HLDGS INC$799,000
-3.0%
13,0260.0%0.11%
-37.3%
QTNT  QUOTIENT LTD$769,000
+44.5%
110,0000.0%0.10%
-6.4%
MOH  MOLINA HEALTHCARE INC$752,000
-16.0%
16,5000.0%0.10%
-45.4%
GWPH  GW PHARMACEUTICALS PLCads$726,000
+8.4%
6,0000.0%0.10%
-29.2%
HCSG SellHEALTHCARE SVCS GRP INC$711,000
-52.3%
16,500
-56.7%
0.10%
-69.0%
ALDR  ALDER BIOPHARMACEUTICALS INC$686,0000.0%33,0000.0%0.09%
-35.0%
DVA  DAVITA INC$680,000
+5.9%
10,0000.0%0.09%
-30.5%
PODD  INSULET CORP$646,000
+14.3%
15,0000.0%0.09%
-25.9%
VAR  VARIAN MED SYS INC$638,000
+1.6%
7,0000.0%0.08%
-34.1%
IART NewINTEGRA LIFESCIENCES HLDGS C$632,00015,000
+100.0%
0.08%
CEMP NewCEMPRA INC$619,000165,000
+100.0%
0.08%
RMD  RESMED INC$576,000
+16.1%
8,0000.0%0.08%
-24.5%
CLDX  CELLDEX THERAPEUTICS INC NEW$578,000
+2.1%
160,0000.0%0.08%
-33.6%
TBPH SellTHERAVANCE BIOPHARMA INC$531,000
+7.9%
14,428
-6.5%
0.07%
-29.7%
TDOC NewTELADOC INC$500,00020,000
+100.0%
0.07%
OBLN  OBALON THERAPEUTICS INC$428,000
+20.9%
40,0000.0%0.06%
-20.8%
PEN  PENUMBRA INC$417,000
+30.7%
5,0000.0%0.06%
-13.8%
 REWALK ROBOTICS LTD$420,000
-25.0%
200,0000.0%0.06%
-51.3%
ACHN SellACHILLION PHARMACEUTICALS IN$417,000
-57.9%
99,000
-58.8%
0.06%
-72.4%
NVAX  NOVAVAX INC$416,000
+1.5%
325,0000.0%0.06%
-34.5%
WBMD  WEBMD HEALTH CORP$390,000
+6.3%
7,4000.0%0.05%
-30.7%
AACH  AAC HLDGS INC$384,000
+17.8%
45,0000.0%0.05%
-23.9%
MYGN SellMYRIAD GENETICS INC$250,000
+7.3%
13,000
-7.1%
0.03%
-31.2%
SGRY SellSURGERY PARTNERS INC$205,000
-13.9%
10,500
-30.0%
0.03%
-44.9%
CERS NewCERUS CORP$134,00030,000
+100.0%
0.02%
EIGR ExitEIGER BIOPHARMACEUTICALS INC$0-3,333
-100.0%
-0.01%
LABU ExitDIREXION SHS ETF TRsp biotech bl new$0-25,175
-100.0%
-0.16%
BIB ExitPROSHARES TR$0-20,500
-100.0%
-0.17%
INSYQ ExitINSYS THERAPEUTICS INC NEW$0-115,000
-100.0%
-0.22%
ARIA ExitARIAD PHARMACEUTICALS INC$0-375,000
-100.0%
-0.96%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Bellevue Asset Management AG #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IONIS PHARMACEUTICALS INC31Q3 20239.3%
Vertex Pharmaceuticals Incorporated31Q3 20235.9%
NEUROCRINE BIOSCIENCES INC31Q3 20235.7%
Incyte Corporation31Q3 20235.4%
INTUITIVE SURGICAL INC31Q3 20234.7%
ABBOTT LABS31Q3 20234.6%
ELEVANCE HEALTH INC31Q3 20234.3%
UnitedHealth Group Incorporated31Q3 20233.6%
ALNYLAM PHARMACEUTICALS INC31Q3 20233.7%
Boston Scientific Corporation31Q3 20232.5%

View Bellevue Group AG's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G2023-02-14
SC 13G2023-02-14
13F-HR2022-11-14

View Bellevue Group AG's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (750412000.0 != 750418000.0)

Export Bellevue Group AG's holdings